Celtuide

Prescription Medicine for Adults with Type 2 Diabetes

CELTUIDE
Once-Weekly GLP-1 Therapy to Help Manage Type 2 Diabetes

CELTUIDE is a prescription semaglutide injection designed to help improve blood sugar control in adults with type 2 diabetes when used along with proper diet and regular physical activity. The once-weekly treatment supports better glucose regulation through GLP-1 receptor activation and convenient prefilled pen delivery.

CELTUIDE is not for weight loss. Individual results may vary.

A Once-Weekly GLP-1 Prescription Therapy Designed for Convenient Diabetes Management

HOW CELTUIDE WORKS

CELTUIDE is a once-weekly GLP-1 receptor agonist therapy designed to help adults with type 2 diabetes improve blood glucose control when used together with a healthy diet and regular physical activity.

Improves Glycaemic Control

CELTUIDE helps lower blood glucose levels by increasing insulin secretion when blood sugar levels are elevated and reducing the amount of glucagon released by the pancreas. This dual action supports improved glycaemic control in adults with type 2 diabetes when used as prescribed.

Once-Weekly Injection

CELTUIDE is designed for once-weekly subcutaneous injection, allowing patients to manage their treatment with a simple dosing schedule. The prefilled injection pen provides accurate dosing and convenient administration that fits easily into a weekly routine.

Cardiovascular Benefit

In adults with type 2 diabetes and established cardiovascular disease, GLP-1 receptor agonists such as semaglutide may help reduce the risk of major cardiovascular events, including heart attack and stroke, when used as part of an appropriate treatment plan.

CELTUIDE is not a substitute for insulin and is not indicated for the treatment of type 1 diabetes.

HOW TO TAKE CELTUIDE

CELTUIDE is administered once weekly as a subcutaneous injection using a prefilled injection pen. Your healthcare provider will determine the appropriate starting dose and adjust the treatment gradually based on your individual needs and response.

01

STEP

Start with a Low Dose

Treatment typically begins with a lower starting dose to help your body adjust to the medication and reduce the likelihood of gastrointestinal side effects. Your healthcare provider will guide you on how to administer the injection correctly using the Celtuide pen.

02

STEP

Gradually Increase the Dose

After the initial treatment period, your doctor may gradually increase the dose depending on your blood sugar response and overall tolerance. This stepwise dose adjustment helps improve glycaemic control while ensuring the treatment remains well tolerated.

03

STEP

Maintain Once-Weekly Use

Once the recommended maintenance dose is reached, Celtuide should be taken once weekly on the same day each week. Consistent weekly administration helps maintain stable blood glucose control as part of your diabetes management plan.

USING THE CELTUIDE PEN

Celtuide is designed for convenient, once-weekly administration using a prefilled injection pen. The pen allows patients to deliver an accurate dose of semaglutide with a simple and easy-to-follow injection process.

Pre-Filled Injection Pen

Celtuide is supplied in a ready-to-use prefilled injection pen containing semaglutide solution and compatible disposable needles. The pen is designed for single-patient use and provides precise dose delivery with a simple dial-a-dose mechanism.

Subcutaneous Injection

Celtuide is administered under the skin (subcutaneously) as directed by your healthcare provider. Common injection sites include the abdomen, thigh, or upper arm. Always use a new sterile needle for each injection and follow the instructions provided by your healthcare professional.

Once-Weekly Routine

Celtuide should be injected once every week on the same day each week. This consistent dosing schedule helps maintain stable blood glucose levels and supports effective long-term diabetes management.

SAFETY & SIDE EFFECTS

Like all prescription medicines, CELTUIDE (semaglutide injection) may cause side effects, although not everyone experiences them. Most side effects are mild to moderate and may improve as your body adjusts to the treatment. Always consult your healthcare provider if you have concerns while using Celtuide.

Common Side Effects

These side effects are the most frequently reported and are usually mild to moderate. They often decrease over time as your body becomes accustomed to the medication.

  • Nausea
  • Vomiting
  • Diarrhoea
  • Constipation
  • Abdominal discomfort or stomach pain
Warnings & Precautions

Use Celtuide exactly as prescribed by your healthcare provider. Inform your doctor before starting treatment if you:

  • Have a history of pancreatic disease
  • Have kidney problems or impaired kidney function
  • Have severe gastrointestinal disorders
  • Are pregnant, planning to become pregnant, or breastfeeding
Serious Side Effects

Although uncommon, serious side effects may occur. Contact your healthcare provider immediately if you experience any of the following symptoms.

  • Severe or persistent abdominal pain
  • Signs of pancreatitis
  • Severe allergic reactions such as swelling, rash, or difficulty breathing
When to Seek Medical Help

Seek immediate medical attention if you experience severe or persistent symptoms, signs of pancreatitis, or any symptoms of a serious allergic reaction while using Celtuide.

Always discuss any unusual symptoms or side effects with your healthcare professional to ensure safe and effective treatment.

WHO SHOULD NOT USE CELTUIDE

Celtuide May Not Be Suitable for Everyone

CELTUIDE is a prescription medicine and may not be appropriate for all individuals. Before starting treatment, it is important to discuss your medical history and current health conditions with your healthcare provider.

Do not use CELTUIDE if any of the following apply to you:

  • You have type 1 diabetes or require insulin as the primary treatment for diabetes
  • You are allergic to semaglutide or any of the ingredients in CELTUIDE
  • You have a history of severe hypersensitivity reactions to GLP-1 receptor agonists
  • Your healthcare provider has advised against using this medication based on your medical condition